This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: JAMA Network Open
Author(s): Chileshe Nkonde-Price, MD, MS; Kristi Reynolds, PhD; Michael Najem, BS; Su-Jau Yang, PhD; Columbus Batiste, MD; Timothy Cotter, MD; Debora Lahti, MSN; Nancy Gin, MD; Tadashi Funahashi, MD

In a recent study comparing modes of cardiac rehabilitation, the authors found that home-based cardiac rehabilitation results in fewer hospitalizations among patients. Because of accessibility issues, many patients who could benefit from cardiac rehabilitation to improve health after cardiac issues do not take advantage of these resources. To remedy this problem, home-based rehabilitation was developed in facilities such as Kaiser Permanente Southern California (KPSC), where this study was conducted. Although previous studies have concluded that home-based and center-based rehabilitation result in similar outcomes, this study encompasses previously unstudied diverse and medically complex populations, allowing for a more inclusive result.

Source: STAT News
Author(s): Shiza Abbasi and Carrie B. Dolan

Historically, investment in surgical care has been limited in low-income countries, where children are fourteen times more likely to die before age five than in high-income countries. The authors argue that with simple and affordable surgical care, children with treatable illnesses such as congenital anomalies, injuries, and infections could be saved. Networks of physicians funded by charitable donation and driven by commitments from the United Nations are integral to providing necessary surgical care, and the authors emphasize that the global health philanthropy community needs to pivot a larger portion of its focus to surgical programs in underserved countries.

Source: The Journal of Thoracic and Cardiovascular Surgery
Author(s): Zara Khachatryan, MD; Johanna Herajärvi, MD, PhD; Sergey Leontyev, MD, PhD; Michael A. Borger, MD, PhD

As one of the most challenging medical emergencies, acute Type A aortic dissection (ATAAD) is associated with increased mortality even when recognized and treated early. This article from Zara Khachatryan, et. al—recently opened to nonsubscribers—describes the benefits of using valve-sparing aortic root replacement, or the David procedure, in patients with ATAAD. The authors found that, especially in younger patients and those with connective tissue disorders, the David procedure is associated with good preoperative safety and long-term efficacy. When performed effectively by experienced surgeons, valve-sparing aortic root replacement has become a desirable option in treating ATAAD in properly selected patients.

Source: News Medical
Author(s): Emily Henderson
A new analysis by a team led by Dr. Mario Gaudino of Weill Cornell Medicine and NewYork-Presbyterian shows that a combination of two antiplatelets drugs can benefit patients after coronary artery bypass graft surgery but also increases the risk of potentially dangerous bleeding. Reported on August 9 in JAMA, the finding suggests physicians should carefully weigh the use of these medications after this procedure.
Source: Annals of Thoracic Surgery
Author(s): Weston G. Andrews, MD, Brian E. Louie, MD, Massimo Castiglioni, MD, Ankit Dhamija, MD, Alex S. Farivar, MD, Joshua Chansky, Peter T. White, MD, Ralph W. Aye, MD, Eric Vallieres, MD, and Adam J. Bograd, MD
Surgical management for potentially resectable stage IIIA-N2 non-small cell lung cancer (NSCLC) is controversial. In this study, researchers examined outcomes of a well-selected surgical cohort of postinduction IIIA-N2 NSCLC patients with persistent N2 disease and found that overall survival for patients with non-R(un) or persistent N2 (true R0) was similar to those with mediastinal downstaging. Authors say this study underscores the importance of classifying the extent of mediastinal involvement for persistent N2 patients, supporting the proposed International Association for the Study of Lung Cancer R(un) classification.
Source: Annals of Thoracic Surgery
Author(s): Alyyah Malick, BA, Yuming Ning, PhD, Paul A. Kurlansky, MD, Andrew Melehy, MD, Melana Yuzefpolskaya, MD, Paolo C. Colombo, MD, Gabriel Sayer, MD, Nir Uriel, MD, MSc, Yoshifumi Naka, MD, PhD, and Koji Takeda, MD, PhD
This study compared the development of de novo aortic insufficiency (AI), the a common adverse event after continuous-flow left ventricular assist device (LVAD) placement, between HeartMate 3 (Abbott) and HeartMate II LVAD recipients. Researchers ultimately concluded there is no significant difference in severity of AI between HeartMate II and HeartMate 3 patients.
Source: Annals of Thoracic Surgery
Author(s): Horacio G. Carvajal, MD, Catherine Gooch, MD, Taylor C. Merritt, CCRN, J. Chancellor Fox, BS, Anne N. Pourney, RN, BSN, Harshini D. Kumaresan, Matthew W. Canter, MET, and Pirooz Eghtesady, MD, PhD
Many congenital heart diseases are tied to genetic defects and can lead to heart failure that requires heart transplant. This paper outlines the outcomes of transplants performed in children with such genetic syndromes and disorders and finds that, despite more preoperative comorbidities, midterm outcomes after heart transplant are promising.
Source: Annals of Thoracic Surgery
Author(s): Saloni Kapoor, MD, Jianhui Zhu, PhD, Arman Kilic, MD, Catalin Toma, MD, Ibrahim Sultan, MD, Floyd Thoma, BS, Conrad Smith, MD, Oscar C. Marroquin, MD, Forozan Navid, MD, Joon S. Lee, MD, and Suresh R. Mulukutla, MD
According to the authors of this paper, surgical risk stratified outcomes after contemporary revascularization strategies have not been well described. This study outlines such outcomes after PCI or CABG in patients with multivessel coronary disease, which the authors say can help guide the revascularization strategy choice for individual patients.
Source: Medwire News
Author(s): Shreeya Nanda
Investigators in the CALGB 140503 recently presented the results of phase 3 of the trial at the IACSLC World Conference on Lung Cancer 2022 in Vienna. The results show that sub-lobar resection is noninferior to lobectomy with respect to disease-free survival and overall survival in patients with clinical stage T1a N0 non-small-cell lung cancer and tumors no larger than 2 cm, among other findings.
Source: Cardiology Advisor
Author(s): Sheila Jacobs
This study was conducted among patients with presurgical atrial fibrillation who had undergone conventional sternotomy heart surgery, deriving from the Heart Surgery in Atrial Fibrillation and Supraventricular Tachycardia (HEIST) registry in Europe from 2010-2021. Investigators of the study sought to build on prior knowledge of preoperative atrial fibrillation procedures, where it is recognized the procedure increases risk for negative patient results following cardiac surgery. Namely, the study assessed long-term measures of mortality following surgical ablation that takes place prior to cardiac surgery procedures. Throughout the study, it was found that the use of concomitant surgical ablation was associated with a significant decrease in mortality: 16 percent compared with patients who had no ablation performed on them.